N/A N=36 Force Modulating Tissue Bridges for Closure of Vertical Scars in Breast Reduction
Surgical Incision
Primary: Patient and Observer Scar Assessment Scale (POSAS)- Patient Scores 12M — 1.09; 1.22; 1.3; 1.87 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=12 Clinical Evaluation of RFAL of Breast Envelope and NAC Position
Breast Lift
Primary: Measurements of Distance (cm) Between Breast Area Reference Points (Nipple to Nipple) — 20.6 centimeters
N/A N=137 Seri Surgical Scaffold Support of the Lower Pole of the Breast
Recurrent Ptosis of the Breast
Primary: Nipple to Fold Measurement on Stretch — 2.3; 2.5; 1.4; 1.4 centimeters
N/A N=15 A Post-Market Study in Greece of a Minimally Invasive Breast Lift Procedure Utilizing the Renuvion APR System
Breast Ptosis
Primary: Independent Photographic Review of Before and After Images Compared to Baseline Compared to D180. — 11 Participants
N/A N=13 Circumferential Periareolar Mastopexy Using SERI Surgical Scaffold
Mastopexy
Primary: Number of Participants With Areolar Dilation of up to 6mm at 12 Months — 13 Participants
N/A N=34 SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery
Subjects Requiring Revision Breast Augmentation Surgery
Primary: Reoperation Rate (Per Implanted Breast) for the Presenting Condition at 12 Months. — 0; 0 Implanted breasts
N/A N=1 Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema
Lymphedema · Edema
Primary: Change in Limb Volume — -15; -202 mL
N/A N=17 Immediate Postmastectomy Breast Reconstruction (Strattice Breast)
Breast Cancer
Primary: Histology Sample Evaluations Assessing Incorporation of StratticeTM Reconstructive Tissue Matrix — 0; 82.8; 17.2; 0 percentage of breasts
N/A N=40 Regenerative Collagen Scaffold for Breast Volume Restoration After Breast Cancer Excision
Breast-Conserving Surgery
Primary: Volume Restoration — 33 Participants
N/A N=104 Low Level Laser Therapy to Reduce Pain After Breast Augmentation Surgery
Pain
Primary: Number of Participants Who Scored Less Than 30 on the 0-100 Visual Analog Scale (VAS)for Pain 24 Hours Post-operative. — 20; 37 participants — p=<0.0001
N/A N=207 TiLoop® Bra for Breast Reconstruction
Patient and Surgical Related Risk Factors for Complications
Primary: Participants Who Received TiLOOP Mesh Reconstruction — 207 Patients with TiLOOP mesh reconstruction
N/A N=100 3D Breast Imaging for Cosmetic and Reconstructive Breast Surgery
Hypomastia · Primary Breast Augmentation
Primary: Breast Q Augmentation Module — 494.5; 503.4; 420 units on a scale
N/A N=45 PEAK PlasmaBlade 4.0 in Bilateral Breast Reduction
Macromastia
Primary: Postoperative Pain — 4.47; 4.66 units on a scale — p=0.4697
N/A N=21 Use of Prineo in Breast Reduction Surgery
Efficiency of Surgical Incision Closure · Post-operative Scar
Primary: Operative Time to Closure of Final Skin Layer — 58.38; 444.76 seconds
Phase 4 N=19 European New Texture Implant Clinical Experience With Shaped Breast Implants
Breast Augmentation
Primary: Investigator Overall Satisfaction With the Device Using a 5-Point Scale — 4.6 score on a scale
N/A N=24 Macrolane for Enhancement of the Shape and Fullness of the Female Breast
Breast Enhancement
Primary: Number of Breasts With Successful Placement of the Implant Posterior to the Mammary Gland at 6 Weeks After Treatment — 48 Breasts
N/A N=50 Evaluation of the Cook Biodesign® Nipple Reconstruction Cylinder (NRC)
Breast Cancer · Breast Reconstruction · Nipple Reconstruction
Primary: Percent Nipple Projection at 12 Months Compared to Baseline (1 Week Post-procedure) — 37.3 percentage of projection vs baseline
N/A N=18 European New Texture Implant Clinical Experience With Round Breast Implants
Breast Augmentation
Primary: Investigator Overall Satisfaction With the Device Using a 5-Point Scale — 4.6 score on a scale
N/A N=162 Asian Outcomes of Primary Breast Augmentation
Breast Augmentation
Primary: Post Surgical Complications and Reoperation Rate During Breast Augmentation — 1.85; 1.85 percentage of participants
N/A N=51 Treatment of Surgical Scars Following Breast Augmentation, Abdominoplasty or Face Lift
Surgical Scar · Breast Augmentation · Abdominoplasty
Primary: Improvement of Surgical Scars at 12 Months Compared to Baseline (Pre-treatment) as Evaluated by 3 Independent Blinded Reviewers Using the General Aesthetic Improvement…
N/A N=162 Tumor: Breast Ratio Study
Breast Cancer · LCIS · DCIS
Primary: Quality of Life as Measured by the Breast Q — 61.9; 57.6; 74.2; 64.2 score on a scale
N/A N=90 Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction
Breast Cancer
Primary: Number of Participants With Complications After Tissue Expander Replacement With Implant — 10; 10 participants
Phase 4 N=79 Study of Prineo (Dermabond Protape) Versus Sutures in Breast Procedures
Macromastia
Primary: Continuous Apposition of the Skin Edges Without Wound Dehiscence or Re-closure as Measured by the Upper Limit of 95% Confidence Interval in Proportion of Successes for…
N/A N=84,329 Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants
Breast Reconstruction
Primary: Local Complications — 15.0; 21.6; 11.1; 10.7 Percentage by Patient
N/A N=100 The SeriScaffold® Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery in Europe
Soft Tissue Support and Repair
Primary: Investigator Satisfaction With Seri® Surgical Scaffold on an 11-Point Scale — 8.8 Scores on a Scale
N/A N=93 Macrolane Retrospective Study
Women Who Have Had Breast Enhancement With Macrolane VRF
Primary: Number of Adverse Events — 46 number of AE
N/A N=94 Observational Study to Assess Long-Term Follow-Up of Breast Augmentation Subjects
Postoperative Pain
Primary: Number of Subjects With Breast Implant Rupture — 0; 0; 0; 0 participants
N/A N=139 The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery
Breast Reconstruction
Primary: Investigator Satisfaction Following Use of SERI® Surgical Scaffold at 6 Months — 9.4 units on a scale
N/A N=715 Safety and Effectiveness of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants
Breast Augmentation · Breast Reconstruction · Revision of Augmentation or Reconstruction
Primary: Local Complications — 18.9; 24.6; 28.7; 6.7 percentage by patient
Phase 2 N=47 Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction
Breast Cancer
Primary: Quality of Recovery Score — 165; 169 score on a scale